Delivery Order SPE2DB20D1109-SPE2DB23FN72S
- Not listed
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The award, valued at $10,633.20, was made to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,290.33 and is a Firm Fixed Price Delivery Order that runs through August 15, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $22,996.75 and a period of performance through July 27, 2023. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $12,444.76 and runs through March 21, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of Otezla 30mg tablets to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $27,230.48 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 22, 2024, with a period of performance through October 23, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,842.24 and a completion date of June 9, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp is a subsidiary...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $11,165.73 and is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The IDC has a maximum value of $999,999,999.00 and runs through November 2026, providing a comprehensive range of pharmaceutical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Otezla 30 mg tablets. The contract, valued at $6,984.12, is a delivery order with a firm fixed price and an ultimate completion date of March 1, 2024. The contract is not designated with a set-aside. It is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $15,330.58, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 30, 2022 with a completion date of March 31, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC,...
- This federal contract award is for the delivery of Otezla (apremilast) 30 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract has a ceiling value of $7,606.81 and is a firm-fixed price delivery order awarded to Amerisourcebergen Drug Corp, the Corporate Office division of the major pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FN72SDelivery Order
This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $23,379.24 and a performance period through March 15, 2023. The contract is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical healthcare commodities to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.4k | 3/14/23 |